Stock CZO CEAPRO INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Ceapro Inc.

Equities

CZO

CA1499071076

Market Closed - Toronto S.E.
Other stock markets
 20:33:12 01/05/2024 BST 		5-day change 1st Jan Change
0.245 CAD +2.08% Intraday chart for Ceapro Inc. +2.08% +28.95%
04-29 Ceapro Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-29 Ceapro Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ceapro Inc. Reports 2023 Financial Results and Operational Highlights
GL
Ceapro Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Ceapro Inc. Reports 2023 Financial Results and Operational Highlights
AQ
Ceapro Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Ceapro Brief: Parties anticipate completing Transaction in Q2 2024, subject to obtaining all required approvals and satisfying all required conditions
MT
Ceapro Brief: Says Received Final Court Approval for Merger with Aeterna Zentaris
MT
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
GL
Aeterna Zentaris Reports Q4 Net Loss of US$5.6 Million, Provides DETECT Trial Update
MT
Aeterna Zentaris Brief: Announcing Completion of Enrollment in Ongoing Pivotal DETECT-Trial for Diagnosis of Childhood-Onset Growth Hormone Deficiency
MT
Aeterna Zentaris Brief: Reporting Q4 Net Loss of US$5.6 million, or $1.16 loss per common share
MT
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
GL
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
AQ
Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business
AQ
Ceapro Brief: Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR Arrangement Agreement to Approve Merger of Equals to Create a Diversified Biopharmaceutical Co
MT
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
GL
Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business
GL
Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris
GL
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro
AQ
Canadian Investment Regulatory Organization Trade Resumption - CZO
AQ
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create Diversified Biopharmaceutical Co
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CZO Stock
  4. News Ceapro Inc.